Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123M Buy
5,922,188
+3,020,981
+104% +$66.8M 0.06% 374
2026
Q1
$67.6M Buy
2,901,207
+2,012,639
+227% +$62.7M 0.04% 531
2025
Q4
$39.3M Buy
888,568
+814,255
+1,096% +$45.7M 0.02% 837
2025
Q3
$5.44M Sell
74,313
-760,128
-91% -$49.6M ﹤0.01% 2144
2025
Q2
$51.2M Sell
834,441
-679,492
-45% -$37.9M 0.04% 567
2025
Q1
$87.9M Buy
1,513,933
+541,776
+56% +$34.2M 0.08% 320
2024
Q4
$51.9M Buy
972,157
+625,467
+180% +$30.6M 0.04% 562
2024
Q3
$15.1M Buy
346,690
+300,839
+656% +$10M 0.01% 1164
2024
Q2
$1.28M Buy
+45,851
New +$1.21M ﹤0.01% 3013
2024
Q1
Sell
-112,156
Closed -$3.14M 4414
2023
Q4
$3.14M Buy
112,156
+23,853
+27% +$563K ﹤0.01% 2302
2023
Q3
$1.87M Buy
88,303
+7,492
+9% +$204K ﹤0.01% 2618
2023
Q2
$2.75M Buy
80,811
+52,417
+185% +$1.75M ﹤0.01% 2368
2023
Q1
$919K Buy
+28,394
New +$942K ﹤0.01% 3218
2022
Q4
Sell
-24,938
Closed -$754K 4911
2022
Q3
$754K Sell
24,938
-59,791
-71% -$2.19M ﹤0.01% 3787
2022
Q2
$2.95M Buy
84,729
+27,947
+49% +$1.1M ﹤0.01% 2732
2022
Q1
$2.96M Sell
56,782
-378,048
-87% -$19M ﹤0.01% 2912
2021
Q4
$21.8M Buy
+434,830
New +$28.3M 0.02% 1026

Other funds holding DOCS

David Shaw's DOCS Position: Q2 2026 in Review

David Shaw increased its Doximity (DOCS) stake by 104% in Q2 2026, buying an estimated $66.8M and bringing the position to 5,922,188 shares worth $123M. The position accounts for 0.06% of the portfolio, ranked #374.

David Shaw first reported a position in DOCS in Q4 2021 and has held it in 17 quarters since. 355 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • David Shaw held 5,922,188 shares of Doximity worth $123M as of Q2 2026.
  • David Shaw bought 3,020,981 Doximity shares in Q2 2026, an estimated $66.8M.
  • Doximity made up 0.06% of David Shaw's portfolio in Q2 2026, its #374 holding.
  • David Shaw first reported a position in Doximity in Q4 2021 and has held it in 17 quarters since.
  • 355 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.